GLOBAL MEDICAL REIT INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.9 USD | +0.11% |
|
+0.11% | -19.82% |
| May. 13 | B. Riley Securities Adjusts Global Medical REIT's Price Target to $10 From $11, Keeps Buy Rating | MT |
| May. 08 | Transcript : Global Medical REIT Inc., Q1 2024 Earnings Call, May 08, 2024 |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 567.2 | 629.3 | 1,140 | 621.1 | 727.8 | 583.7 | - | - |
| Enterprise Value (EV) 1 | 567.2 | 1,210 | 1,704 | 621.1 | 727.8 | 1,229 | 1,214 | 1,203 |
| P/E ratio | 132 x | -76.8 x | 93.4 x | 47.4 x | 48.3 x | 396 x | 141 x | 223 x |
| Yield | 6.05% | 6.13% | 4.62% | 8.86% | - | 9.44% | 9.61% | 10% |
| Capitalization / Revenue | 8.02 x | 6.71 x | 9.83 x | 4.52 x | 5.16 x | 4.2 x | 4.07 x | 3.97 x |
| EV / Revenue | 8.02 x | 12.9 x | 14.7 x | 4.52 x | 5.16 x | 8.84 x | 8.47 x | 8.18 x |
| EV / EBITDA | 11 x | 23 x | 20.3 x | 6.52 x | 7.64 x | 13.1 x | 11.7 x | 10.4 x |
| EV / FCF | - | -6,608,668 x | - | - | - | - | - | - |
| FCF Yield | - | -0% | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 42,872 | 48,188 | 64,208 | 65,518 | 65,565 | 65,588 | - | - |
| Reference price 2 | 13.23 | 13.06 | 17.75 | 9.480 | 11.10 | 8.900 | 8.900 | 8.900 |
| Announcement Date | 3/4/20 | 3/3/21 | 2/28/22 | 2/28/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 70.73 | 93.73 | 115.9 | 137.3 | 141 | 138.9 | 143.3 | 147.1 |
| EBITDA 1 | 51.7 | 52.53 | 84 | 95.2 | 95.2 | 94.07 | 103.3 | 115.9 |
| EBIT 1 | 27.06 | 16.18 | 37.12 | 38.47 | 37.07 | 34.83 | - | - |
| Operating Margin | 38.26% | 17.26% | 32.02% | 28.02% | 26.28% | 25.07% | - | - |
| Earnings before Tax (EBT) | 9.588 | -2.499 | - | - | - | - | - | - |
| Net income 1 | 3.412 | -7.747 | 11.8 | 13.32 | 14.79 | 0.2522 | 3.837 | 3.243 |
| Net margin | 4.82% | -8.27% | 10.18% | 9.7% | 10.49% | 0.18% | 2.68% | 2.2% |
| EPS 2 | 0.1000 | -0.1700 | 0.1900 | 0.2000 | 0.2300 | 0.0225 | 0.0633 | 0.0400 |
| Free Cash Flow | - | -183.2 | - | - | - | - | - | - |
| FCF margin | - | -195.41% | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.8000 | 0.8000 | 0.8200 | 0.8400 | - | 0.8400 | 0.8550 | 0.8933 |
| Announcement Date | 3/4/20 | 3/3/21 | 2/28/22 | 2/28/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 30.34 | 31.88 | 33.7 | 35.41 | 36.31 | 36.23 | 36.35 | 35.51 | 32.96 | 35.12 | 34.33 | 34.68 | 35.13 | 35.66 | 35.94 |
| EBITDA 1 | 21.88 | 22.27 | 23.27 | 24.65 | 25 | 24.85 | 24.66 | 23.91 | 21.78 | 23.29 | 24.32 | 24.23 | 24.54 | 25.17 | 25.59 |
| EBIT 1 | 9.232 | 9.087 | 9.235 | 10.24 | 9.912 | 9.959 | 9.859 | 9.714 | 7.535 | 9.204 | 8.65 | 8.611 | 8.362 | - | - |
| Operating Margin | 30.42% | 28.51% | 27.41% | 28.92% | 27.3% | 27.49% | 27.12% | 27.36% | 22.86% | 26.21% | 25.2% | 24.83% | 23.8% | - | - |
| Earnings before Tax (EBT) | - | 4.286 | 3.834 | 10.03 | - | - | - | - | - | - | - | - | - | - | - |
| Net income 1 | 3.804 | 2.661 | 2.236 | 8.057 | 0.369 | 0.673 | 11.82 | 3.138 | -0.84 | 0.794 | -0.1495 | -0.008 | 0.1254 | 0.3672 | 0.684 |
| Net margin | 12.54% | 8.35% | 6.64% | 22.76% | 1.02% | 1.86% | 32.52% | 8.84% | -2.55% | 2.26% | -0.44% | -0.02% | 0.36% | 1.03% | 1.9% |
| EPS 2 | 0.0600 | 0.0400 | 0.0300 | 0.1200 | 0.0100 | 0.0100 | 0.1800 | 0.0500 | -0.0100 | 0.0100 | -0.005000 | 0.005000 | 0.005000 | 0.0100 | 0.0100 |
| Dividend per Share 2 | 0.2050 | 0.2100 | 0.2100 | 0.2100 | 0.2100 | 0.2100 | 0.2100 | 0.2100 | - | - | 0.2100 | 0.2100 | 0.2100 | 0.2150 | 0.2150 |
| Announcement Date | 2/28/22 | 5/4/22 | 8/3/22 | 11/2/22 | 2/28/23 | 5/3/23 | 8/2/23 | 11/6/23 | 2/27/24 | 5/7/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 581 | 565 | - | - | 645 | 630 | 619 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 11.06 x | 6.721 x | - | - | 6.857 x | 6.099 x | 5.34 x |
| Free Cash Flow | - | -183 | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex | - | - | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - | - | - |
| Announcement Date | 3/4/20 | 3/3/21 | 2/28/22 | 2/28/23 | 2/27/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
8.9
USD
Average target price
10.38
USD
Spread / Average Target
+16.57%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -19.82% | 584M | |
| +12.32% | 60.56B | |
| -1.87% | 19.76B | |
| +0.45% | 14B | |
| -0.10% | 7.57B | |
| -7.89% | 6.01B | |
| +12.06% | 3.56B | |
| +0.46% | 3.32B | |
| -4.32% | 3.15B | |
| +2.04% | 3.01B |
- Stock Market
- Equities
- GMRE Stock
- Financials Global Medical REIT Inc.
